Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

This study has been completed.
Sponsor:
Collaborator:
Anapharm
Information provided by:
Par Pharmaceutical, Inc.
ClinicalTrials.gov Identifier:
NCT00653055
First received: April 1, 2008
Last updated: April 3, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2001
  Primary Completion Date: December 2001 (Final data collection date for primary outcome measure)